相关实验视频

Updated: Jun 14, 2025

Author Spotlight: Standardizing and Improving the Extraction and Purification of Extracellular Vesicles from Human ADSCs

Author Spotlight: Standardizing and Improving the Extraction and Purification of Extracellular Vesicles from Human ADSCs

Published on: May 3, 2024

人类脂肪介质干细胞衍生的外体细胞通过抑制 keloids 中的铁质减轻纤维化

Yuan Tian¹, Meijia Li¹, Rong Cheng¹

¹Plastic Surgery, Harbin Medical University, Harbin, China.

Frontiers in pharmacology

|September 2, 2024

概括

脂肪酸衍生的介质干细胞外生体 (ADSC-Exos) 显示出通过抑制铁灭症来治疗 keloids 的潜力. 这项研究表明,ADSC-Exos通过向SLC7A11-GPX4通路来对抗胆固醇纤维化,从而提供了一种新的治疗策略.

科学领域:

生物医学研究生物医学研究
细胞生物学细胞生物学
皮肤病学皮肤病学

背景情况:

体是具有高复发率的挑战性纤维扩散性疾病.
目前的 keloid 治疗方法的疗效有限.
脂肪酸衍生中干细胞外体 (ADSC-Exos) 显示出治疗纤维状况的前景.

研究的目的:

为了研究ADSC-Exos在 keloids中的抗纤维效应.
探索铁质在 keloid 发育和 ADSC-Exos 治疗中的作用.
阐明ADSC-Exos在 keloids中的作用背后的分子机制.

主要方法:

在 keloid 纤维细胞上使用铁灭菌诱导剂 (Erastin) 和抑制剂 (ferrostatin-1).
与ADSC-Exos一起共同培养的 keloid 细胞.
分析了蛋白质和基因表达 (GPX4,SLC7A11),铁代谢标志物 (MDA,LPO,GSH),并进行了体外和体内评估.

主要成果:

埃拉斯诱导的铁,加剧了 keloid 纤维化.
通过调节铁代谢,ADSC-Exos和ferrostatin-1显示出抗纤维的作用.
ADSC-Exos治疗增加了GSH和GPX4的表达,通过SLC7A11-GPX4通路抑制了 keloid 纤维化.

结论:

抗ferroptosis策略可以抑制 keloid 纤维化进展.
ADSC-Exos代表着一种潜在的治疗方法.
向铁和SLC7A11-GPX4通路为 keloid 治疗提供了一个新的治疗策略.

关键词:

在GPx4中使用.脂肪衍生的中介细胞干细胞.细胞外囊泡中的细胞外囊泡.铁性铁性铁性铁性纤维化纤维化

更多相关视频

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Published on: September 23, 2022

Author Spotlight: Advancing Treatment Approaches with Adipose-Derived Stem Cells

Author Spotlight: Advancing Treatment Approaches with Adipose-Derived Stem Cells

Published on: January 12, 2024

相关概念视频

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...